Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06059638 · ClinicalTrials.gov registry record · NA
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A NA study of Hypertension and Hypertension, Systolic, sponsored by Orchestra BioMed.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 20
- Study locations
NCT06059638 is a NA study of Hypertension and Hypertension, Systolic that is actively recruiting participants, run by Orchestra BioMed. The registered enrollment target is 500 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The trial reports 20 study locations across 6 states.
The verdict
NCT06059638, a NA study of Hypertension and Hypertension, Systolic, is actively recruiting participants, sponsored by Orchestra BioMed.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 20
- Study locations
Study Summary
A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.
Conditions Studied
Interventions
- DEVICE Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated
- DEVICE Medtronic Astra/Azure DR MRI IPG with AVIM therapy Deactivated
Study Locations (20)
Florida
- HCA Florida JFK Hospital - Atlantis
- Cardiovascular Research Solutions (MyCardiologist) - Celebration
- Clearwater Cardiovascular Consultants - Clearwater
- Citrus Cardiology Consultants - Crystal River
- The Cardiac and Vascular Institute - Gainesville
- Memorial Healthcare System - Hollywood
- Baptist Health Jacksonville - Jacksonville
- Baptist Health South Florida - Miami
- Mount Sinai Medical Center of Florida - Miami Beach
- Sarasota Memorial Hospital - Sarasota
California
- Adventist Health Glendale - Glendale
- Stanford - Redwood City
- Scripps Clinic - San Diego
- Sutter Valley Hospitals - San Francisco
Colorado
- South Denver Cardiology - Denver
- Intermountain Health Lutheran Hospital - Golden
Georgia
- Piedmont Healthcare, Inc. - Atlanta
- Wellstar Research Institute - Marietta
Arizona
- HonorHealth - Scottsdale
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-12-27 |
| Est. Completion | 2029-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06059638
The ClinicalTrials.gov registry entry for NCT06059638 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The listed sponsor is Orchestra BioMed, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated is the first listed.
NCT06059638 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Florida, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT06059638 about?
NCT06059638 is a clinical study titled "BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT". A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.
What is the current status of trial NCT06059638?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-12-27. Estimated completion is 2029-08.
What conditions does trial NCT06059638 study?
This clinical trial studies the following conditions: Hypertension, Hypertension, Systolic, Hypertension, Essential.
What interventions are being tested in trial NCT06059638?
The interventions under investigation include: Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated (DEVICE), Medtronic Astra/Azure DR MRI IPG with AVIM therapy Deactivated (DEVICE).
Who is sponsoring clinical trial NCT06059638?
This trial is sponsored by Orchestra BioMed, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06059638 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.